John F Kennedy
CIK 1138315 · last filed 2021-03-26
John F Kennedy is a corporate insider who has filed 43 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for HBIO, was dated Mar 26, 2021. Across all open-market trades the lifetime net is +$91.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $269.0K across reported positions. 36 SEC filings were submitted jointly with HARVARD BIOSCIENCE INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HART price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7700 FRANCE AVE. SOUTH
EDINA, MN 55435
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HBIO | Director | 32,334 | $8.32 | $269.0K | $8.7K | 30 | 2021-03-26 |
| Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted | Director | — | — | — | $0 | 1 | 2017-03-16 |
| Harvard Apparatus Regenerative Technology, Inc. (BSTG) Delisted | Director | 2,920 | — | — | $25.2K | 2 | 2016-08-29 |
| Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted | Director | 35,724 | $30.67 | $1.10M | $57.3K | 10 | 2016-03-24 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-26 | HBIO | Gift (G) | −6,895 | $0 | EDGAR |
| 2021-03-19 | HBIO | Gift (G) | −12,500 | $0 | EDGAR |
| 2021-01-06 | HBIO | Grant (A) | +13,200 | $0 | EDGAR |
| 2020-08-10 | HBIO | Gift (G) | −7,500 | $0 | EDGAR |
| 2020-08-04 | HBIO | Gift (G) | −6,830 | $0 | EDGAR |
| 2020-07-23 | HBIO | Gift (G) | −6,830 | $0 | EDGAR |
| 2020-07-17 | HBIO | Gift (G) | −6,830 | $0 | EDGAR |
| 2020-07-14 | HBIO | Gift (G) | −6,830 | $0 | EDGAR |
| 2020-06-19 | HBIO | Mixed | +24,566 | $0 | EDGAR |
| 2020-01-03 | HBIO | Grant (A) | +24,200 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.